A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities

Gokmen, T.; Oguz, S.; Bozdag, S.; Erdeve, ÖMER; Uras, N.; Dilmen, U.

doi:10.1038/jp.2011.56

A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities

Atıf İçin Kopyala

Gokmen T., Oguz S. S., Bozdag S., Erdeve Ö., Uras N., Dilmen U.

JOURNAL OF PERINATOLOGY, cilt.32, sa.2, ss.123-128, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 2
Basım Tarihi: 2012
Doi Numarası: 10.1038/jp.2011.56
Dergi Adı: JOURNAL OF PERINATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.123-128
Anahtar Kelimeler: preterm, feeding intolerance, erythromycin, ursodeoxycholic acid, cholestasis, URSODEOXYCHOLIC ACID TREATMENT, ORAL ERYTHROMYCIN, PRETERM INFANTS, CHOLESTASIS, CONTRACTIONS, THERAPY
Ankara Üniversitesi Adresli: Evet

Özet

Objective: To compare the effectiveness of oral erythromycin versus ursodeoxycholic acid (UDCA) treatment in preventing feeding intolerance and liver function abnormalities.